Allstocks.com's Bulletin Board Post New Topic  New Poll  Post A Reply
my profile login | register | search | faq | forum home

  next oldest topic   next newest topic
» Allstocks.com's Bulletin Board » Micro Penny Stocks, Penny Stocks $0.10 & Under » sswc

 - UBBFriend: Email this page to someone!    
Author Topic: sswc
m69jump
Member


Rate Member
Icon 14 posted      Profile for m69jump     Send New Private Message       Edit/Delete Post   Reply With Quote 
http://stockcharts.com/h-sc/ui
IP: Logged | Report this post to a Moderator
m69jump
Member


Rate Member
Icon 1 posted      Profile for m69jump     Send New Private Message       Edit/Delete Post   Reply With Quote 
http://ih.advfn.com/p.php?pid=nmona&article=43372008&symbol=SSWC
IP: Logged | Report this post to a Moderator
m69jump
Member


Rate Member
Icon 1 posted      Profile for m69jump     Send New Private Message       Edit/Delete Post   Reply With Quote 
Date : 06/28/2010 @ 11:07AM
Source : MarketWire
Stock : SpeechSwitch, Inc. (SSWC)
Quote : 0.0021 0.0002 (10.53%) @ 11:30AM


SpeechSwitch, Inc. (USOTC: SSWC) Filing Health Care Patent Applications for Advanced Biodegradable Wound Care Products
SpeechSwitch,. Class A (OTC) (USOTC:SSWC)
Intraday Stock Chart
Today : Monday 28 June 2010

Ken Glynn, President of SpeechSwitch, Inc. (PINKSHEETS: SSWC), announced today that the Health Care Division is developing three new inventions and filing three patent applications relating to wound care. One of the inventions involves biodegradable, disposable band-aids and bandages utilizing biodegradable support strips and adhesives with natural algae biomimetic artificial skin material that accelerates healing and absorbs naturally into the body. A second invention utilizing the same wound care technology involves other treatment enhancements included within the biomimetic artificial skin material. The third invention is a collaboration between Dr. Alain Martin and Ken Glynn, as co inventors, utilizing the same wound care technology, but including Dr. Martin's proprietary antioxidant, anti-inflammatory cell growth accelerants. Dr. Martin is the inventor of Neosporin and other successful products, and is currently the CEO of North Cell Pharmaceutical, Inc. SpeechSwitch and North Cell will be equal partners in this alliance.

In other news, Ken announced that he will be interviewed today by the Wall Street Reporter and that the interview will be posted later this week.

Information set forth in this press release contains various "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. The Private Securities Litigation reform Act of 1995 (the "Act") provides certain "safe harbor" provisions for forward-looking statements. The reader is cautioned that such forward-looking statements are based on information available at the time and/or management's good faith belief with respect to future events, and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed statements. Forward-looking statements speak only as of the date the statement was made. We assume no obligation to update forward-looking information to reflect actual results, changes in assumptions or changes in other factors affecting forward-looking information. Forward-looking statements are typically identified by the use of terms such as "anticipate," "believe," "could," "estimate," "expect," "intend," "may," "might," "plan," "predict," "project," "should," "will," and similar words, although some forward-looking statements are expressed differently. Although we believe that the expectations reflected in such forward-looking statements are reasonable, we can give no assurance that such expectations will prove to be correct.

Contact:

Ken Glynn

908 788 0077

IP: Logged | Report this post to a Moderator
   

Quick Reply
Message:

HTML is not enabled.
UBB Code™ is enabled.

Instant Graemlins
   


Post New Topic  New Poll  Post A Reply Close Topic   Feature Topic   Move Topic   Delete Topic next oldest topic   next newest topic
 - Printer-friendly view of this topic
Hop To:


Contact Us | Allstocks.com Message Board Home

© 1997 - 2021 Allstocks.com. All rights reserved.

Powered by Infopop Corporation
UBB.classic™ 6.7.2

Share